Molecular Pharmacology

Research Frontiers in Mammalian Target of Rapamycin Complex Selective Inhibition

Development of second-generation mTOR inhibitors achieving selective mTORC1 or mTORC2 inhibition to improve therapeutic efficacy in cancer and metabolic disease.

All Molecular Pharmacology PhD categories